Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 75

Similar articles for PubMed (Select 24422111)

1.

Vitamin D therapy limits osteoclast precursor migration.

[No authors listed]

Bonekey Rep. 2013 Jul 17;2:391. doi: 10.1038/bonekey.2013.125. eCollection 2013. No abstract available.

2.

Sphingosine-1-phosphate-mediated osteoclast precursor monocyte migration is a critical point of control in antibone-resorptive action of active vitamin D.

Kikuta J, Kawamura S, Okiji F, Shirazaki M, Sakai S, Saito H, Ishii M.

Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):7009-13. doi: 10.1073/pnas.1218799110. Epub 2013 Apr 8.

3.

Mechanism in inhibitory effects of vitamin K2 on osteoclastic bone resorption: in vivo study in osteopetrotic (op/op) mice.

Kawata T, Zernik JH, Fujita T, Tokimasa C, Tanne K.

J Nutr Sci Vitaminol (Tokyo). 1999 Aug;45(4):501-7.

PMID:
10575640
4.

Apoptotic osteocytes regulate osteoclast precursor recruitment and differentiation in vitro.

Al-Dujaili SA, Lau E, Al-Dujaili H, Tsang K, Guenther A, You L.

J Cell Biochem. 2011 Sep;112(9):2412-23. doi: 10.1002/jcb.23164.

PMID:
21538477
6.

The Rho GTPase Wrch1 regulates osteoclast precursor adhesion and migration.

Brazier H, Pawlak G, Vives V, Blangy A.

Int J Biochem Cell Biol. 2009 Jun;41(6):1391-401. doi: 10.1016/j.biocel.2008.12.007. Epub 2008 Dec 24.

PMID:
19135548
7.

Risedronate reduces osteoclast precursors and cytokine production in postmenopausal osteoporotic women.

D'Amelio P, Grimaldi A, Di Bella S, Tamone C, Brianza SZ, Ravazzoli MG, Bernabei P, Cristofaro MA, Pescarmona GP, Isaia G.

J Bone Miner Res. 2008 Mar;23(3):373-9.

PMID:
17967134
9.

Bone morphogenetic protein 2 enhances mouse osteoclast differentiation via increased levels of receptor activator of NF-κB ligand expression in osteoblasts.

Tachi K, Takami M, Zhao B, Mochizuki A, Yamada A, Miyamoto Y, Inoue T, Baba K, Kamijo R.

Cell Tissue Res. 2010 Nov;342(2):213-20. doi: 10.1007/s00441-010-1052-y. Epub 2010 Oct 13.

PMID:
20941510
10.

Vitamin D antagonist, TEI-9647, inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D3 from pagetic bone marrow cells.

Ishizuka S, Kurihara N, Miura D, Takenouchi K, Cornish J, Cundy T, Reddy SV, Roodman GD.

J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):331-4.

PMID:
15225795
11.

Anti-osteoclastogenic action of active vitamin D.

Takasu H.

Nutr Rev. 2008 Oct;66(10 Suppl 2):S113-5. doi: 10.1111/j.1753-4887.2008.00098.x. Review.

PMID:
18844837
12.

Implication of the calcium sensing receptor and the Phosphoinositide 3-kinase/Akt pathway in the extracellular calcium-mediated migration of RAW 264.7 osteoclast precursor cells.

Boudot C, Saidak Z, Boulanouar AK, Petit L, Gouilleux F, Massy Z, Brazier M, Mentaverri R, Kamel S.

Bone. 2010 May;46(5):1416-23. doi: 10.1016/j.bone.2010.01.383. Epub 2010 Feb 10.

PMID:
20149906
13.

Inhibition of osteoclast formation by 3-methylcholanthrene, a ligand for arylhydrocarbon receptor: suppression of osteoclast differentiation factor in osteogenic cells.

Naruse M, Otsuka E, Naruse M, Ishihara Y, Miyagawa-Tomita S, Hagiwara H.

Biochem Pharmacol. 2004 Jan 1;67(1):119-27.

PMID:
14667934
14.

Vitamin D hormone inhibits osteoclastogenesis in vivo by decreasing the pool of osteoclast precursors in bone marrow.

Shibata T, Shira-Ishi A, Sato T, Masaki T, Masuda A, Hishiya A, Ishikura N, Higashi S, Uchida Y, Saito MO, Ito M, Ogata E, Watanabe K, Ikeda K.

J Bone Miner Res. 2002 Apr;17(4):622-9.

PMID:
11918219
15.

Actin polymerization modulates CD44 surface expression, MMP-9 activation, and osteoclast function.

Samanna V, Ma T, Mak TW, Rogers M, Chellaiah MA.

J Cell Physiol. 2007 Dec;213(3):710-20.

PMID:
17508356
16.

Osteoclast progenitors from cats with and without tooth resorption respond differently to 1,25-dihydroxyvitamin D and interleukin-6.

Booij-Vrieling HE, de Vries TJ, Schoenmaker T, Tryfonidou MA, Penning LC, Hazewinkel HA, Everts V.

Res Vet Sci. 2012 Apr;92(2):311-6. doi: 10.1016/j.rvsc.2011.03.014. Epub 2011 Apr 16.

PMID:
21497870
17.

Osteocyte apoptosis regulates osteoclast precursor adhesion via osteocytic IL-6 secretion and endothelial ICAM-1 expression.

Cheung WY, Simmons CA, You L.

Bone. 2012 Jan;50(1):104-10. doi: 10.1016/j.bone.2011.09.052. Epub 2011 Oct 1.

PMID:
21986000
18.

Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.

Cao JJ, Wronski TJ, Iwaniec U, Phleger L, Kurimoto P, Boudignon B, Halloran BP.

J Bone Miner Res. 2005 Sep;20(9):1659-68. Epub 2005 May 2.

PMID:
16059637
19.

High extracellular calcium inhibits osteoclast-like cell formation by directly acting on the calcium-sensing receptor existing in osteoclast precursor cells.

Kanatani M, Sugimoto T, Kanzawa M, Yano S, Chihara K.

Biochem Biophys Res Commun. 1999 Jul 22;261(1):144-8.

PMID:
10405337
20.

1 alpha,25-dihydroxyvitamin D3 up-regulates expression of the osteoclast integrin alpha v beta 3.

Medhora MM, Teitelbaum S, Chappel J, Alvarez J, Mimura H, Ross FP, Hruska K.

J Biol Chem. 1993 Jan 15;268(2):1456-61.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk